|
Meta regression interpretation, significant coefficient with no association
|
|
5
|
384
|
March 17, 2021
|
|
Glossary of Statistical Terms
|
|
29
|
9109
|
March 16, 2021
|
|
Debunking myths: intention to treat , missing follow-up and imputation
|
|
6
|
526
|
March 15, 2021
|
|
Sample size requirements for a proportional odds model
|
|
7
|
467
|
March 15, 2021
|
|
Provisions for outilers and strategies
|
|
2
|
203
|
March 15, 2021
|
|
How to create the real splines values for the rcs and %ia% functions in the rms package?
|
|
4
|
369
|
March 14, 2021
|
|
Cross sectional study design and analysis technique for evaluating impact of COVID 19 on radiotherapy quality of care indicators
|
|
1
|
240
|
March 13, 2021
|
|
Recommended Reading: Pay No Atttention to the Model Behind the Curtain by Philip B. Stark
|
|
0
|
264
|
March 11, 2021
|
|
Is it possible to plot cumulative incidence curves from nested case-control studies?
|
|
5
|
399
|
March 11, 2021
|
|
A question on "rms" package
|
|
1
|
173
|
March 11, 2021
|
|
Meta-epidemiology study in diagnostic accuracy studies reporting diagnostic odds ratios
|
|
3
|
309
|
March 10, 2021
|
|
Sequential Survival Models
|
|
1
|
175
|
March 10, 2021
|
|
Reporting Generalized Wilcoxon for Survival Analysis
|
|
6
|
879
|
March 9, 2021
|
|
Language for communicating frequentist results about treatment effects
|
|
181
|
40403
|
March 9, 2021
|
|
Sample size estimation for growth as an outcome
|
|
1
|
134
|
March 9, 2021
|
|
Reference Collection to push back against "Common Statistical Myths"
|
|
42
|
36380
|
March 8, 2021
|
|
Confusing results from Scottish study of real-world effectiveness of Pfizer and Oxford/ Astra Zeneca vaccines
|
|
1
|
747
|
March 8, 2021
|
|
Wish item: URL Links to open in new tabs
|
|
3
|
165
|
March 8, 2021
|
|
Musing on how to design "statistical functions/methods 2.0"
|
|
3
|
332
|
March 7, 2021
|
|
Proportional odds with repeated measurements
|
|
1
|
168
|
March 7, 2021
|
|
Median Overall Survival and Right Censoring
|
|
4
|
254
|
March 6, 2021
|
|
Principal Components analysis - any useful hints and references
|
|
1
|
192
|
March 5, 2021
|
|
Multilevel modeling and appropriate use of clusters
|
|
1
|
209
|
March 5, 2021
|
|
Multiple comparison method after Kruskal Wallis test
|
|
7
|
549
|
March 4, 2021
|
|
Advice on study design
|
|
6
|
357
|
March 3, 2021
|
|
An adverse-event graphic
|
|
19
|
866
|
March 3, 2021
|
|
Advice on which sampling method to use
|
|
0
|
131
|
March 2, 2021
|
|
Mathematical behavior of the primary endpoint
|
|
13
|
3354
|
March 2, 2021
|
|
Bayesian Re-Analysis of Clinical Trial Data
|
|
19
|
5592
|
March 2, 2021
|
|
ANDROMEDA-SHOCK (or, how to intepret HR 0.76, 95% CI 0.55-1.02, p=0.06)
|
|
73
|
16758
|
January 27, 2020
|
